OP0273 Effects of Tumor Necrosis Factor Alpha on Cytokine Secretion of Synovial Fluid-Derived Mesenchymal Stem Cell-like Cells. (15th July 2016)
- Record Type:
- Journal Article
- Title:
- OP0273 Effects of Tumor Necrosis Factor Alpha on Cytokine Secretion of Synovial Fluid-Derived Mesenchymal Stem Cell-like Cells. (15th July 2016)
- Main Title:
- OP0273 Effects of Tumor Necrosis Factor Alpha on Cytokine Secretion of Synovial Fluid-Derived Mesenchymal Stem Cell-like Cells
- Authors:
- Vereb, Z.
Váncsa, A.
Pilling, M.
Petrovski, G.
Szekanecz, Z. - Abstract:
- Abstract : Background: Rheumatoid arthritis is characterized by painful joint swelling, cartilage and bone destruction, chronic inflammation of the synovium (synovitis) with the accumulation of synovial fluid into the joint cavity. Within the synovial fluid the number of MSC-like cells (SYF-MSC) is increasing during the active phase of the disease. MSC are able to mediate immunosuppression via cell-cell contact and secreted factors respectively. Objectives: Our goal was to screen the secreted proteins by SYF-MSCs under pro-inflammatory conditions. Methods: Synovial fluid was harvested from patients with active RA (according to the Guidelines of the Helsinki Declaration). The isolated fluid/cells were cultured in vitro, their expression of well-known MSC markers as well as their differentiation potential was tested. SYF-MSCs were treated with human recombinant TNF alpha (TNFa) for 24 hour than the secreted cytokines were determined by high throughput protein array. Results: SYF-MSCs secreted aggrecan, angiogenin, chitinase 3 like-1, Dkk-1, DPPIV, EMMPRIN, FGF-19, GM-CSF, IGFBP-3, IL-6, IL-17A, MCP-1, PDGF-AA, Pentraxin-3, Resistin, SDF-1α and Thrombospondin-1 under normal condition. Treatment by TNFa decreased the level of the secreted chitinase 3 like-1 (544003±56200.85; Pixel density, Mean±SD) and Dkk-1 (388062.5±10488.51) compared to untreated controls (721671.5±10434.77 and 705830±16013.14). Beside this phenomenon the pro-inflammatory provocation increased the secretionAbstract : Background: Rheumatoid arthritis is characterized by painful joint swelling, cartilage and bone destruction, chronic inflammation of the synovium (synovitis) with the accumulation of synovial fluid into the joint cavity. Within the synovial fluid the number of MSC-like cells (SYF-MSC) is increasing during the active phase of the disease. MSC are able to mediate immunosuppression via cell-cell contact and secreted factors respectively. Objectives: Our goal was to screen the secreted proteins by SYF-MSCs under pro-inflammatory conditions. Methods: Synovial fluid was harvested from patients with active RA (according to the Guidelines of the Helsinki Declaration). The isolated fluid/cells were cultured in vitro, their expression of well-known MSC markers as well as their differentiation potential was tested. SYF-MSCs were treated with human recombinant TNF alpha (TNFa) for 24 hour than the secreted cytokines were determined by high throughput protein array. Results: SYF-MSCs secreted aggrecan, angiogenin, chitinase 3 like-1, Dkk-1, DPPIV, EMMPRIN, FGF-19, GM-CSF, IGFBP-3, IL-6, IL-17A, MCP-1, PDGF-AA, Pentraxin-3, Resistin, SDF-1α and Thrombospondin-1 under normal condition. Treatment by TNFa decreased the level of the secreted chitinase 3 like-1 (544003±56200.85; Pixel density, Mean±SD) and Dkk-1 (388062.5±10488.51) compared to untreated controls (721671.5±10434.77 and 705830±16013.14). Beside this phenomenon the pro-inflammatory provocation increased the secretion of IL-6 (from 79140±6940.96 to 615191±73256.26), MCP-1 (283985.5±25964.25 to 846348±81354.05), furthermore induced the release of IL-(8743315±71580.42) IL-24 (32189±29555.65) and RANTES (641698±26383.57). Unlike untreated cells no resistin, empirin and SDF-1 could be detected after TNFa exposure. Conclusions: The in vitro data suggest that TNFa is able to turn SYF-MSCs to a pro-inflammatory phenotype, which may play a role in the inflammatory processes of RA prolonging the active phase of the disease. Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 75(2016)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 75(2016)Supplement 2
- Issue Display:
- Volume 75, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 75
- Issue:
- 2
- Issue Sort Value:
- 2016-0075-0002-0000
- Page Start:
- 161
- Page End:
- 162
- Publication Date:
- 2016-07-15
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2016-eular.1359 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18013.xml